Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...
The FDA on Wednesday approved the industry’s first-ever tablet treatment for spinal muscular atrophy— Roche ’s SMN2 splicing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback